Bayer Aktiengesellschaft Stock Fundamentals
BAYA Stock | EUR 4.80 0.14 2.83% |
Bayer Aktiengesellschaft fundamentals help investors to digest information that contributes to Bayer Aktiengesellscha's financial success or failures. It also enables traders to predict the movement of Bayer Stock. The fundamental analysis module provides a way to measure Bayer Aktiengesellscha's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bayer Aktiengesellscha stock.
Bayer |
Bayer Aktiengesellschaft Company Shares Outstanding Analysis
Bayer Aktiengesellscha's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Bayer Aktiengesellscha Shares Outstanding | 3.93 B |
Most of Bayer Aktiengesellscha's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bayer Aktiengesellschaft is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, Bayer Aktiengesellschaft has 3.93 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The shares outstanding for all Germany stocks is significantly lower than that of the firm.
Bayer Aktiengesellschaft Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bayer Aktiengesellscha's current stock value. Our valuation model uses many indicators to compare Bayer Aktiengesellscha value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bayer Aktiengesellscha competition to find correlations between indicators driving Bayer Aktiengesellscha's intrinsic value. More Info.Bayer Aktiengesellschaft is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bayer Aktiengesellschaft is roughly 2.26 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bayer Aktiengesellscha's earnings, one of the primary drivers of an investment's value.Bayer Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bayer Aktiengesellscha's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bayer Aktiengesellscha could also be used in its relative valuation, which is a method of valuing Bayer Aktiengesellscha by comparing valuation metrics of similar companies.Bayer Aktiengesellscha is currently under evaluation in shares outstanding category among its peers.
Bayer Fundamentals
Return On Equity | 0.13 | |||
Return On Asset | 0.0576 | |||
Current Valuation | 82.93 B | |||
Shares Outstanding | 3.93 B | |||
Shares Owned By Institutions | 0.10 % | |||
Price To Earning | 12.22 X | |||
Price To Book | 1.32 X | |||
Price To Sales | 1.00 X | |||
Revenue | 44.08 B | |||
Gross Profit | 30.87 B | |||
EBITDA | 6.45 B | |||
Net Income | 1000 M | |||
Cash And Equivalents | 8.19 B | |||
Cash Per Share | 2.09 X | |||
Total Debt | 35.55 B | |||
Debt To Equity | 1.13 % | |||
Current Ratio | 1.23 X | |||
Book Value Per Share | 10.50 X | |||
Cash Flow From Operations | 5.09 B | |||
Earnings Per Share | 1.17 X | |||
Price To Earnings To Growth | 1.28 X | |||
Target Price | 15.3 | |||
Number Of Employees | 102.3 K | |||
Beta | 1.17 | |||
Market Capitalization | 55.35 B | |||
Total Asset | 120.24 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.04 % | |||
Five Year Return | 4.07 % | |||
Net Asset | 120.24 B |
About Bayer Aktiengesellscha Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bayer Aktiengesellschaft's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bayer Aktiengesellscha using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bayer Aktiengesellschaft based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER ADR is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in Bayer Stock
Bayer Aktiengesellscha financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer Aktiengesellscha security.